Do common dopaminergic variants modulate processing speed in cognitive aging? A longitudinal candidate gene study

Area of Science:

• Neuroscience
• Genetics
• Public Health

Background:

• Cognitive aging is a significant public health concern due to global population aging.
• Processing speed decline is a hallmark of cognitive aging and a predictor of dementia risk.
• Dopaminergic system integrity is linked to cognitive performance in aging, but the role of common genetic variants is not well understood.

Purpose of the Study:

• To investigate the influence of common dopaminergic genetic variants on 12-year processing speed decline.
• To assess the impact of these variants on cognitive performance at age 70 and other cognitive domains.
• To explore associations with post-mortem neuropathology and synaptic density.

Main Methods:

• Analysis of 89 linkage disequilibrium-independent variants across nine dopamine pathway genes in 1,539 participants.
• Utilized single-variant, gene-based, and pathway allele score analyses.
• Included exploratory post-mortem analyses of neuropathology and synaptic density.

Main Results:

• No dopaminergic genetic variants or pathway scores were significantly associated with processing speed decline or performance after correcting for multiple testing.
• Nominal associations were observed for specific variants (e.g., DRD2, DBH) but did not withstand stringent statistical correction.
• Null findings were consistent across cognitive domains and post-mortem analyses.

Conclusions:

• Common genetic variation in the dopamine pathway does not appear to have moderate-to-large effects on cognitive aging trajectories.
• The study lacked sufficient power to detect smaller genetic effects.
• Alternative genetic mechanisms (rare variants, epigenetics) or gene-environment interactions may contribute to individual differences in cognitive aging.